Keith T. Flaherty
- Oncology top 0.01%
- Cutaneous Melanoma Detection and Management 86
- CAR-T cell therapy research 75
- Colorectal Cancer Treatments and Studies 65
- Cancer Immunotherapy and Biomarkers 62
- HER2/EGFR in Cancer Research 55
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics 66
- Molecular Biology top 0.05%
- Melanoma and MAPK Pathways 277
- Immunology top 0.1%
- Pulmonary and Respiratory Medicine top 0.1%
-
- Computational Drug Discovery Methods 43
- Co-authors
- Antoni RibasPeter J. O’DwyerRyan J. SullivanGrant A. McArthurGeorgina V. LongPaul B. ChapmanDavid E. FisherJennifer A. Wargo
- Journals
- Journal of Clinical Oncology (164 papers)Clinical Cancer Research (44 papers)Cancer Research (26 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Keith T. Flaherty
498 papers receiving 39.1k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Oncology 24.8k
- Cancer Research 5.7k
- Molecular Biology 23.3k
- Immunology 7.1k
- Pulmonary and Respiratory Medicine 6.3k
Countries citing papers authored by Keith T. Flaherty
This map shows the geographic impact of Keith T. Flaherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith T. Flaherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith T. Flaherty more than expected).
Fields of papers citing papers by Keith T. Flaherty
This network shows the impact of papers produced by Keith T. Flaherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith T. Flaherty. The network helps show where Keith T. Flaherty may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keith T. Flaherty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 37 | |
| 2 | 2019 | 102 | |
| 3 | 2019 | 65 | |
| 4 | 2017 | 240 | |
| 5 | 2016 | 119 | |
| 6 | 2016 | 138 | |
| 7 | 2015 | 46 | |
| 8 | 2015 | 31 | |
| 9 | 2014 | 192 | |
| 10 | 2014 | 96 | |
| 11 | 2014 | 85 | |
| 12 | A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitorsbreakdown → | 2014 | 357 |
| 13 | 2013 | 29 | |
| 14 | 2012 | 184 | |
| 15 | 2011 | 250 | |
| 16 | 2011 | 295 | |
| 17 | Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Functionbreakdown → | 2010 | 574 |
| 18 | 2007 | 118 | |
| 19 | 2007 | 176 | |
| 20 | 2007 | 416 |
About Keith T. Flaherty
Keith T. Flaherty is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 518 papers that have together received 39.7k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (277 papers), Cutaneous Melanoma Detection and Management (86 papers), CAR-T cell therapy research (75 papers), Cancer Genomics and Diagnostics (66 papers), Colorectal Cancer Treatments and Studies (65 papers), Cancer Immunotherapy and Biomarkers (62 papers), HER2/EGFR in Cancer Research (55 papers) and Computational Drug Discovery Methods (43 papers). The work is most often cited by research in Oncology (24.8k citations), Cancer Research (5.7k citations) and Molecular Biology (23.3k citations). Keith T. Flaherty has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Antoni Ribas, Peter J. O’Dwyer, Ryan J. Sullivan, Grant A. McArthur, Georgina V. Long, Paul B. Chapman, David E. Fisher, Jennifer A. Wargo, David A. Barbie and Russell W. Jenkins. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.